CHRS Analyst Ratings 2026
Coherus Oncology Inc - Wall Street recommendations & price targets
Consensus Rating
N/A
Current Price
$1.99
Get Complete CHRS Analysis
AI insights, DCF valuation, and institutional ownership
View Full AnalysisFrequently Asked Questions
What is the analyst rating for CHRS?
Analyst rating data for CHRS is being updated. Check back for the latest Wall Street recommendations.
What is the CHRS price target?
Price target data for CHRS is being updated.
Is CHRS a buy according to analysts?
Check the latest analyst recommendations for CHRS.
How many analysts cover CHRS?
Analyst coverage information for CHRS is being updated.